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ABSTRACT
Background: Retinoblastoma is the most common intraocular
tumour in children, with the average age at diagnosis varying
from 12 months in bilateral cases to 23 months for unilateral
tumours. Extraocular disease has a far lower survival rate
than the intraocular one. In the developed world, more than
90% of patients with retinoblastoma survive, however in the
developing world, where retinoblastoma exists primarily as an
extraocular disease, relatively few patients survive because of 
late presentation and paucity of treatment options.
2Presented here is the case report of a 4 / -month old male
1
Nigerian baby, who presented with a 2-week history of rapidly
progressive painful proptosis of the right eye. Examination
revealed a firm fungating mass arising from the right orbit
which had pushed the globe supero-nasally. There was severe
right lower lid oedema and marked conjunctival chemosis
inferiorly, but the cornea was clear. The patient also had right
leukocoria. The left eye was normal. An ultrasound scan
showed a huge right ocular tumour, solid in consistency with
heterogeneous architecture, which appeared to be growing
from the superior margin of the globe; the finding was
reported to be consistent with retinoblastoma. 
Due to the rapidly progressive and necrotic nature of the
tumour, a lid-sparing modified exenteration was done. The
histopathology findings were consistent with a diagnosis of
undifferentiated retinoblastoma. About two weeks after
surgery there was tumour recurrence but this regressed
following commencement of chemotherapy by the paediatric
oncology unit. 
The tumour recurred despite aggressive chemotherapy
and the patient eventually died 6 months later.
Conclusion: Retinoblastoma in Third World countries is still a
fatal disease, unlike in developed countries where it has a
survival rate of over 90%. Poverty and non availability of
sophisticated diagnostic tools make early detection difficult
thus increasing mortality from the disease. 
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INTRODUCTION
Retinoblastoma is the most common primary intraocular
malignancy of childhood in all racial groups.  In developing1
countries, advanced stages are common. The average age at
diagnosis varies from 12 months in bilateral cases to 23
months for unilateral tumours.  The incidence of1
retinoblastoma is estimated to be between 1 in 15,000 and 1
in 34,000 births.   2,3
Retinoblastoma is a life-threatening disease and survival
depends on how advanced the disease is at presentation. The
survival rate for diagnosis of extraocular symptoms is far
lower than for intraocular disease. In the developed world,
more than 90% of patients with retinoblastoma survive.  In4
the developing world, however, retinoblastoma exists
primarily as an extraocular disease and relatively few
patients survive because of late presentation and paucity of
treatment options.  5
Although leukocoria and strabismus are the most
common presenting signs of retinoblastoma, a retrospective
study by Abramson et al. identified 32 distinct presenting
signs of retinoblastoma.6-8 
A few other studies have also noted some distinct
characteristics exhibited by children whose conditions were
diagnosed in the first year of life.  Not only are these9,10
children diagnosed at a younger age, their laterality is
different (most commonly bilateral when diagnosed in the
first year). In addition, they have a greater tendency to
develop a subsequent intraocular tumour after treatment. 
Early age at diagnosis does not guarantee an early stage
of intraocular or extraocular disease; rather it is associated
with significant mortality.
CASE REPORT
G.J is a four-and-half month-old male baby (6.4kg weight)
who presented at our outpatient clinic on 11  April, 2008th
with a 2-week history of rapidly progressive painful
protrusion of the right eye. The patient was referred from the
paediatric clinic of the same hospital. The mother reported
that the child had normal eyes at birth and was doing well
until 2 weeks prior to presentation when she noticed a small
growth in the inferior part of the eye around the lower lid.
Over the course of 2 weeks, the swelling rapidly increased in
size causing protrusion of the right eye. The baby became
very ill and restless, and was unable to breastfeed. 
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There was no history of fever, redness of the eye, or
trauma to the eye. Pregnancy and birth histories were
uneventful but the child had neonatal jaundice at one week.
His developmental milestones were appropriate for age. The
patient was the first and only child of his parents (child’s
mother was a 19-year old secondary school leaver while the
father was a second year undergraduate) and there was no
known family history of retinoblastoma. 
General systemic examination revealed a well-fed baby
in obvious pain, afebrile (axillary temperature of 37.2 C), noto
pale, anicteric but had a dry tongue. 
External eye examination revealed complete
ophthalmoplegia with severe right lower lid oedema and
hyperemia; the upper lid was normal and freely mobile over
the globe. The superior conjunctiva and sclera were white
while in the inferior half, there was marked conjunctival
injection and chemosis (fig. 1). Arising inferiorly was a firm
fungating mass which had pushed the globe supero-nasally.
The cornea was clear with a shallow anterior chamber and a
mid-dilated unreactive pupil. There was leukocoria and no
red reflex on funduscopy (fig. 1). There was complete
ophthalmoplegia. The left eye was normal. 
An initial diagnosis of right orbital cellulitis to rule out
congenital retinoblastoma and embryonal sarcoma was
made. The patient had already been started on systemic
antibiotics (intravenous ceftriazone 50mg/kg/day, genticin
5mg/kg/day and metronidazole 21mg/kg/day) before
referral to the eye clinic, so he continued on them while some
investigations were requested. Some tests (skull x-ray, FBC,
ESR and blood film plus eye swab for microscopy/culture/
sensitivity) were already ordered by the paediatricians
though none had been done when the patient came to the
clinic. An orbital CT scan was immediately ordered but due
to financial constraints this could not be done, instead an
oculo-orbital ultrasound scan was done. On B-scan
ultrasonography, a huge right ocular mass, solid in
consistency with heterogeneous architecture and which
appeared to be growing from the superior margin of the
globe was seen. The mass compressed the lens and anterior
chamber making the structures indistinguishable. The
appearance was suggestive of retinoblastoma. 
Apart from a raised ESR (85 mm/hr), other
haematological and chemical pathological results were
within normal limits. Due to the rapidly progressive and
necrotic nature of the tumour (fig. 2), a lid-sparing modified
exenteration was done. At surgery, the vitreous popped out
and was found to be clear. The immediate post-operative
period was uneventful but two and a half weeks after
surgery, there was a recurrence of the tumour in the right
orbit.
The histopathology reported a 3-piece irregularly
shaped tissue; the largest measuring 6 x 4.5 x 4 cm and the
smallest 2.5 x 1.5 x 1cm. On gross examination of the cut
surface, a necrotic mass with areas of haemorrhage and
cavitation were seen. 
Microscopic examination revealed round blue cells with
hyperchromic pleomorphic nuclei and scanty cytoplasm,
arranged in sheets and crossed by fibrous bands. No rosettes
were seen, rather areas of tumour necrosis were observed.
These findings were consistent with a diagnosis of
undifferentiated retinoblastoma.
About three weeks after surgery and following
recurrence of the tumour in the right inferior orbit, the
patient was commenced on chemotherapy by the
paediatricians (Vincristine, Actinomycin D and
Cyclophosphamide). A week after commencing
chemotherapy, the tumour started to regress only to recur
one month later (fig. 3).
Figure 1. Baby GJ (17  April 2008)th
Figure 2. Baby GJ (21  April 2008)st
Figure 3. Orbital recurrence following modified exenteration
and chemotherapy (21  May 2008)st
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The chemotherapeutic regimen was changed to
etoposide, vincristine and carboplatin but this did not halt
tumour progression. Despite aggressive chemotherapy, it
continued to increase in size and invaded the right nasal
cavity. The patient eventually died in October 2008.
DISCUSSION
Heritable retinoblastoma presents earlier compared to
sporadic cases.  This case had no family history, but due to11
the early presentation was initially considered to be heritable
(spontaneous germ-line mutation).
Retinoblastoma is usually diagnosed during the first
three years of life, with the average age of diagnosis being 18
months. It is almost never found at birth except when there
is a positive family history, which usually prompts an early
fundus examination. Familial retinoblastoma has been
diagnosed as early as 1-2 weeks after birth  and within the12
first 3-4 months of life.  In Nigeria it has been found to occur13
in babies as young as 5 months old,  though the mean age at14
diagnosis is about 33 months with bilateral neoplasia14,15 
presenting in much younger children than unilateral
disease.  Studies have shown that about two-thirds of15,16
cases of bilateral retinoblastoma present within the first 6
months of life compared to one-third of cases for unilateral
disease.10
To the best of our knowledge, no case of unilateral
retinoblastoma with a rapidly progressive proptosis has been
reported in Nigeria, though elsewhere congenital advanced
unilateral retinoblastoma had been reported in a newborn
who had no family history of retinoblastoma.  17
There are numerous reports of unusual presentations of
retinoblastoma in the literature.  A rare case of retino-17-19
blastoma presenting as a congenital primary intracranial
tumour was reported in a 7-day-old infant who presented
with generalized seizures and had a family history of retino-
blastoma.  Another case of bilateral congenital retino-18
blastoma was reported in a 2-month old baby in Brazil;  the19
right eye was phthisical. Many cases of retinoblastoma
occurring in a microophthalmic eye have also been reported
in the literature. Most reported cases of congenital20-24 
retinoblastoma have been outside the Africa continent.3,6,7,18,19
In patients with unilateral retinoblastoma, the risk of the 
hereditary form is about 10%. Thus, patients with both 
bilateral and hereditary unilateral diseases are at high risk 
(45%) of having offspring with retinoblastoma. Parents12 
whose children are at risk of developing retinoblastoma
therefore require careful counselling with regard to the
likelihood of tumour development and visual sequelae and 
the likelihood of fatality.  12
This case was poorly-differentiated and agrees with
previous studies which indicate that poorly-differentiated
retinoblastoma is more common among African children
than well-differentiated retinoblastoma. Though1 5 ,1 6  
conservative modalities can now be successfully applied in
small tumours, the advanced stage of the disease at
presentation meant that modified exenteration was the only
option in this case. This treatment modality (lid-sparing
modified exenteration with chemotherapy) is similar to the
other cases reported.14,17, 19 
Postoperative tumour recurrence has been found to be
more common in bilateral cases.  This case however25
differed; though unilateral, it had early postoperative
recurrence. Studies have also shown that a good number of
patients who had unilateral disease diagnosed in the first 6
months of life subsequently developed bilateral disease.10, 26 
About two weeks after surgery, there was tumour
recurrence but this regressed following commencement of
chemotherapy. The patient developed further recurrence
despite aggressive chemotherapy and eventually died in
October 2008.
CONCLUSION 
Retinoblastoma in Third World countries is still a fatal
disease compared to developed countries where the survival
rate is over 90%. Poverty and non availability of
sophisticated diagnostic tools make early detection difficult
thus increasing mortality from the disease. 
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